These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 27699391)

  • 1. Euglycemic Ketoacidosis Caused by Sodium-Glucose Cotransporter 2 Inhibitors: A Case Report.
    Bobart SA; Gleason B; Martinez N; Norris K; Williams SF
    Ann Intern Med; 2016 Oct; 165(7):530-532. PubMed ID: 27699391
    [No Abstract]   [Full Text] [Related]  

  • 2. Euglycemic diabetic ketoacidosis with canagliflozin: Not-so-sweet but avoidable complication of sodium-glucose cotransporter-2 inhibitor use.
    Clement M; Senior P
    Can Fam Physician; 2016 Sep; 62(9):725-8. PubMed ID: 27629668
    [No Abstract]   [Full Text] [Related]  

  • 3. ‘Euglycemic’ Ketoacidosis in a Patient With Type 2 Diabetes Being Treated With Canagliflozin.
    Danford C; Chan P; Magill SB
    WMJ; 2016 Aug; 115(4):206-9. PubMed ID: 29099159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Euglycemic ketoacidosis : a complication of SGLT2 inhibitors].
    Mizuno A; Lolachi S; Pernet A
    Rev Med Suisse; 2017 May; 13(565):1164-1167. PubMed ID: 28639760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic Acidosis in Postsurgical Patient on Canagliflozin and Metformin: A Case Report.
    Darwish AM
    A A Pract; 2019 Apr; 12(7):221-222. PubMed ID: 30234515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Euglycemic Diabetic Ketoacidosis with Persistent Diuresis Treated with Canagliflozin.
    Adachi J; Inaba Y; Maki C
    Intern Med; 2017; 56(2):187-190. PubMed ID: 28090050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sodium-glucose Cotransporter 2 Inhibitor-induced Diabetic Ketoacidosis in a Type 2 Diabetic Patient.
    Ramirez Tello EM; Orellana-Barrios MA; Nugent K
    Am J Med Sci; 2016 Jun; 351(6):634-5. PubMed ID: 27238930
    [No Abstract]   [Full Text] [Related]  

  • 8. Sodium-glucose cotransporter 2 inhibitors and diabetic ketoacidosis.
    Bloomgarden ZT
    J Diabetes; 2016 Mar; 8(2):175-6. PubMed ID: 26611882
    [No Abstract]   [Full Text] [Related]  

  • 9. Ketonuria/ketonemia associated with the use of sodium-glucose cotransporter 2 (SGLT-2) inhibitors in type 2 diabetes: A report of three cases from New Delhi, India.
    Ghosh A; Gupta R; Misra A
    J Diabetes; 2016 Sep; 8(5):738-9. PubMed ID: 27085074
    [No Abstract]   [Full Text] [Related]  

  • 10. Combined metformin-associated lactic acidosis and euglycemic ketoacidosis.
    Schwetz V; Eisner F; Schilcher G; Eller K; Plank J; Lind A; Pieber TR; Mader JK; Eller P
    Wien Klin Wochenschr; 2017 Sep; 129(17-18):646-649. PubMed ID: 28865058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EUGLYCEMIC DIABETIC KETOACIDOSIS AND SEVERE ACUTE KIDNEY INJURY SECONDARY TO OFF LABEL USE OF SODIUM GLUCOSE COTRANSPORTER-2 INHIBITOR IN A TYPE-1 DIABETIC PATIENT.
    Tahir H; Wani A; Daruwalla V; Daboul N; Sagi J
    J Ayub Med Coll Abbottabad; 2015; 27(4):923-4. PubMed ID: 27004352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Normoglycemic ketoacidosis in a postoperative gastric bypass patient taking canagliflozin.
    Bonanni FB; Fei P; Fitzpatrick LL
    Surg Obes Relat Dis; 2016 Jan; 12(1):e11-2. PubMed ID: 26686305
    [No Abstract]   [Full Text] [Related]  

  • 13. [Diabetic ketoacidosis with mild hyperglycemia associated with the use of canagliflozin. Report of one case with type 1 diabetes].
    Novik A V; García B C; Oliva I D
    Rev Med Chil; 2017 Mar; 145(3):393-396. PubMed ID: 28548198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sodium-glucose cotransporter 2 inhibitor-associated diabetic ketoacidosis: Report of two cases with hyperglycemic ketoacidosis in type 1 diabetes.
    Harati H; Sharma V; Motazedi A
    J Diabetes; 2016 Jan; 8(1):165. PubMed ID: 26211700
    [No Abstract]   [Full Text] [Related]  

  • 15. Insights Into the Recognition and Management of SGLT2-Inhibitor-Associated Ketoacidosis: It's Not Just Euglycemic Diabetic Ketoacidosis.
    Dizon S; Keely EJ; Malcolm J; Arnaout A
    Can J Diabetes; 2017 Oct; 41(5):499-503. PubMed ID: 28797889
    [No Abstract]   [Full Text] [Related]  

  • 16. Ketosis and diabetic ketoacidosis in response to SGLT2 inhibitors: Basic mechanisms and therapeutic perspectives.
    Qiu H; Novikov A; Vallon V
    Diabetes Metab Res Rev; 2017 Jul; 33(5):. PubMed ID: 28099783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Euglycemic diabetic ketoacidosis in type 2 diabetes treated with a sodium-glucose cotransporter-2 inhibitor.
    Jazi M; Porfiris G
    Can Fam Physician; 2016 Sep; 62(9):722-4. PubMed ID: 27629667
    [No Abstract]   [Full Text] [Related]  

  • 18. In brief: ketoacidosis with SGLT2 inhibitors.
    Med Lett Drugs Ther; 2015 Jun; 57(1471):94. PubMed ID: 26079766
    [No Abstract]   [Full Text] [Related]  

  • 19. Euglycemic diabetic ketoacidosis in type 2 diabetes with sodium glucose cotransporter 2 inhibitors.
    Wang AY; Hou SK; Li SJ; Kao WF
    Am J Emerg Med; 2017 Feb; 35(2):379.e5-379.e6. PubMed ID: 27614369
    [No Abstract]   [Full Text] [Related]  

  • 20. Atypical Ketoacidosis and Protracted Hyperglycosuria after Treatment with Ipragliflozin, an SGLT2 Inhibitor.
    Miyauchi M; Toyoda M; Fukagawa M
    Intern Med; 2017; 56(13):1673-1678. PubMed ID: 28674356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.